Pelvic Inflammatory Disease
Clinical detail
Additional detail checked 2026-10-17 against the linked sources. This check covers the section below; the rest of the module retains its displayed verification status.
PID is a clinical diagnosis with a low threshold for treatment because delayed treatment can impair reproductive health. Excluding pregnancy and surgical emergencies remains part of the assessment.
Assessment & interpretation
- Consider PID with pelvic or lower abdominal pain, no better explanation and cervical-motion, uterine or adnexal tenderness.
- Test for pregnancy, gonorrhoea, chlamydia, HIV and syphilis. Imaging helps when tubo-ovarian abscess or another diagnosis is suspected; a negative cervical test does not exclude upper-tract infection.
Decisions that change management
- For suitable nonpregnant outpatients, the CDC regimen is ceftriaxone 500 mg IM once, plus doxycycline 100 mg orally twice daily for 14 days and metronidazole 500 mg orally twice daily for 14 days.
- Pregnancy, severe illness, abscess, inability to tolerate outpatient treatment or an unresolved surgical differential warrants hospital assessment. The routine doxycycline outpatient regimen is not a pregnancy pathway.
Follow-up & safety-netting
- Clinical improvement should occur within 72 hours; lack of improvement requires reassessment and possible admission.
- Arrange partner evaluation and treatment. Avoid intercourse until treatment is completed, symptoms resolve and partners are treated.
Clinical pitfalls
- Pain resolution does not demonstrate microbiological cure or remove the need for partner care.
Admission & discharge
Admission/discharge guidance checked 2026-10-18 against the linked sources. This is a clinical checklist for an individual decision, not an automatic discharge order.
When admission or continued hospital care is needed
- CDC admission criteria include pregnancy, tubo-ovarian abscess, severe illness/vomiting or temperature >38.5°C, inability to tolerate/follow oral therapy, lack of response, or inability to exclude a surgical emergency.
When clinic, day care or home care may be suitable
- Selected mild/moderate PID can be treated outside hospital if oral treatment, adherence and follow-up are feasible.
Before going home
- Pain, fever and pelvic findings are improving; oral intake/treatment is feasible and the remaining course is supplied.
- After parenteral treatment, oral transition is usually after 24–48 hours of clinical improvement. A tubo-ovarian abscess requires more than 24 hours of inpatient observation and a source-control plan when indicated.
Discharge medicines and treatment changes
- Complete 14 days total therapy in the selected regimen, counting inpatient doses. Doxycycline/metronidazole step-down requires the appropriate nonpregnant context; pregnancy needs specialist inpatient treatment.
Medicine doses — use only when indicated
Use the medicines selected for this patient. Listed alternatives are not instructions to prescribe all of them together. Confirm the actual remaining course, pregnancy/postnatal context and monitoring plan.
Nonpregnant PID oral component only when selected; pregnancy is an admission criterion.
- Indication: Non-pregnant PID; combine with ceftriaxone and metronidazole
- Clinical response within 72 h and oral tolerance; check pregnancy and partner management
Remaining anaerobic-cover component of the selected complete course.
- Indication: Anaerobic cover in the complete CDC PID regimen
- Clinical response within 72 h and tolerance
Tests, pending results and their reviewer
- Review STI tests and any imaging/abscess findings; arrange partner testing/treatment and results callback.
Home care and counselling
- Avoid sex until treatment is completed, symptoms resolved and partners treated; discuss reinfection and fertility risks.
Follow-up: when and what to review
| When | Action / responsible service |
|---|---|
Within 72 hours of outpatient treatment | Confirm clinical improvement; no response needs reassessment/hospital treatment. |
3 months if gonorrhoea/chlamydia associated | Retest for reinfection; follow the abscess/specialist review plan when relevant. |
Return urgently
- Worsening pain, fever, vomiting, fainting or no improvement within 72 hours requires urgent reassessment.
Open the complete discharge checklist →
Treatment
① Immediate stabilization — first minutes
- Admission triggers: TOA, severe illness/vomiting, pregnancy, failed outpatient, surgical abdomen uncertainty
③ First-line treatment & drug regimens
| Setting | Regimen |
|---|---|
Outpatient (non-pregnant) | Ceftriaxone 500 mg IM x1 + Doxycycline 100 mg BD x14 d + Metronidazole 500 mg BD x14 d |
Inpatient | Ceftriaxone 1 g IV q24h (or cefoxitin/ampicillin protocols) + doxycycline + metronidazole; step-down oral to complete 14 d |
④ Drug treatment detail (4 agents)
- Indication: Mild/moderate PID in a NON-PREGNANT patient suitable for outpatient treatment
- Clinical improvement within 72 h, STI results, adherence, partner treatment and pregnancy test
- Indication: Hospitalised PID, with appropriate combination antibiotics
- Clinical response, cultures, oral tolerance and abscess/source-control assessment
- Indication: Non-pregnant PID; combine with ceftriaxone and metronidazole
- Clinical response within 72 h and oral tolerance; check pregnancy and partner management
- Indication: Anaerobic cover in the complete CDC PID regimen
- Clinical response within 72 h and tolerance
Monitoring
- Clinical review 72 h
- Repeat STI testing; partner therapy mandatory
- IUD management decision (usually remove if not improving)
⑮ Complications & their management
Tubo-ovarian abscess
IV antibiotics; imaging-guided drainage >5-7 cm; surgery for rupture/no response
Hydrosalpinx/infertility sequelae
Fertility counselling later; ectopic-risk flag next pregnancies
Fitz-Hugh-Curtis
Perihepatitis responds to standard PID therapy
Post-treatment care
- Abstinence until partner completion; retest guidance
- Documentation for chronic-pain/fertility follow-up
Diagnosis & assessment
- Tubu-ovarian abscess rupture -> emergency laparotomy
- Pregnancy-associated PID -> admit
- No improvement 72 h -> reimagine/drain
Initial assessment
See treatment table for testing and regimens.
Principles & follow-up
Management principles
Sources (7)
2021-07 · updated 2025-12-22 (page review; guidance itself unchanged) · checked 2026-08-23 · verified-live
Open source ↗
CDC pages + wall chart: uncomplicated gonorrhoea cervix/urethra/rectum → ceftriaxone 500 mg IM single dose (<150 kg; 1 g if ≥150 kg); pharyngeal same; conjunctivitis 1 g IM; DGI 1 g IV/IM q24h; PID outpatient → ceftriaxone 500 mg IM ×1 + doxycycline 100 BD ×14 d + metronidazole 500 BD ×14 d; chlamyd…
· checked 2026-10-18 · verified-live
Open source ↗
Scope: additional clinical-detail explanation for pid. Checked the assessment, management-decision and follow-up statements in that section against this source. This does not certify all pre-existing regimens, calculations or recommendations in the module. Additional admission/discharge check 18 Oct…
· checked 2026-10-18 · verified-live
Open source ↗
Maternal/newborn transfer assessment, first void and effective feeding, handover, support/safeguarding, first midwife visit within 36 hours after transfer, postnatal danger symptoms. Full recommendations page read.
· checked 2026-10-18 · verified-live
Open source ↗
Normal-delivery discharge not less than 48 hours: full primary SOP PDF normal-delivery/discharge passages read. Corroborated by NHM CEmONC 2024 Part 1, chapter 8. This does not define a universal post-caesarean or complicated-case stay.
· checked 2026-10-18 · verified-live
Open source ↗
Official WHO summary read: at least 24-hour facility care after birth; additional contacts at 48–72 hours, 7–14 days and week 6; individual assessment/support. Summary facts only, not a claim that the full 242-page PDF was reviewed.
· checked 2026-10-18 · verified-live
Open source ↗
Full primary patient recovery page read: pain control, wounds, activity/VTE, urinary/bowel and infection warning signs, adult support and no driving/important decisions during the first 24 hours after general anaesthesia. Used as general recovery/handover principles, not operation-specific discharge…
· checked 2026-10-18 · verified-live
Open source ↗
Full primary recommendations read, focusing on critical-care-to-ward transfer: structured written handover, shared plan, monitoring, rehabilitation and receiving-team capability. Step-down is distinct from home discharge; no universal organ-support discharge cutoff is asserted.